3D Global Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	17.45	56.12	21.82	15.53	20.37
Short-Term Investments	459.8	647.74	144.2	192.9	212.8
Cash & Short-Term Investments	477.25	703.86	166.02	208.43	233.17
Cash Growth	-32.20%	323.97%	-20.35%	-10.61%	-15.74%
Accounts Receivable	71.98	119.58	1.35	1.09	1.23
Other Receivables	1	2.99	0.59	0.44	0.41
Receivables	72.98	122.57	1.94	1.53	1.64
Inventory	22.38	7.04	3.6	3.37	0.88
Other Current Assets	1.9	2.34	4.12	2.68	4.15
Total Current Assets	574.51	835.81	175.67	216.01	239.85
Property, Plant & Equipment	59.82	92.77	13.15	21.02	28.17
Long-Term Investments	355.6	-	-	-	-
Other Intangible Assets	73.17	87.79	102.29	117.09	152.3
Long-Term Deferred Tax Assets	26.21	18.56	16.27	15.31	3.2
Other Long-Term Assets	1.34	2.65	16.77	1.84	0.99
Total Assets	1,091	1,038	324.15	371.26	424.52
Accounts Payable	2.77	16.08	3.33	2.22	0.67
Accrued Expenses	-	14.34	7.69	7.61	6.35
Current Portion of Leases	7.02	11	6.3	6.37	5.5
Current Unearned Revenue	14.4	6.63	7.31	2.22	-
Other Current Liabilities	16.61	4.41	1.87	1.74	2.44
Total Current Liabilities	40.8	52.46	26.49	20.17	14.95
Long-Term Leases	41.63	73.77	4.08	10.38	15.81
Long-Term Deferred Tax Liabilities	23.69	6.65	-	-	3.94
Other Long-Term Liabilities	-	-	0.11	0.11	0.11
Total Liabilities	106.12	132.88	30.68	30.66	34.81
Common Stock	778.4	778.4	568.09	557.4	539.7
Additional Paid-In Capital	37.76	34.59	1.22	2.08	1.8
Retained Earnings	211.39	91.7	-275.84	-218.88	-151.79
Treasury Stock	-43.02	-	-	-	-
Shareholders' Equity	984.53	904.69	293.47	340.6	389.71
Total Liabilities & Equity	1,091	1,038	324.15	371.26	424.52
Total Debt	48.66	84.76	10.38	16.75	21.31
Net Cash (Debt)	428.59	619.1	155.64	191.68	211.87
Net Cash Growth	-30.77%	297.78%	-18.80%	-9.53%	-17.22%
Net Cash Per Share	5.41	8.75	2.77	3.49	3.93
Filing Date Shares Outstanding	76.87	77.84	56.81	55.74	53.97
Total Common Shares Outstanding	76.87	77.84	56.81	55.74	53.97
Working Capital	533.71	783.35	149.17	195.84	224.9
Book Value Per Share	12.81	11.62	5.17	6.11	7.22
Tangible Book Value	911.36	816.91	191.18	223.52	237.41
Tangible Book Value Per Share	11.86	10.49	3.37	4.01	4.40
Machinery	-	20.25	14.61	14.38	13.77
Leasehold Improvements	-	13.15	12.57	12.57	12.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.